GSK launched a rare £2bn share buyback and raised its growth targets on the back of strong sales of speciality medicines, ...

A task force has been set up to look into how to spend a £2m GSK legacy as the pharmaceutical giant closes its doors in Ulverston. Giles ...

The provision of renewable energy solutions to GSK demonstrates a long-term commitment ... is expected to generate around 52 per cent of the factory’s energy demand. However, some locals have ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Chief executive Emma Walmsley said ministers must work with the sector to boost investment amid growing concerns about doing ...

Now, GSK is ready to play catch up after nabbing its own FDA approval. The FDA approved the British drugmaker's Penmenvy vaccine to protect people ages 10 to 25 against meningococcal serogroups A ...

GSK said it now e American depositary shares of GSK jumped more than 8% Wednesday after the drugmaker reported better-than-expected quarterly results and boosted its long-term sales forecast.

Feb 14 (Reuters) - Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK (GSK.L), opens new tab, the Financial Times reported on Friday. Citadel has ...

The boss of pharma giant GSK has said the Government must 'step ... It comes after AstraZeneca scrapped plans for a £450million vaccine factory near Liverpool following a row with Labour over ...

The provision of renewable energy solutions to GSK demonstrates a long-term commitment to the site ... comrade The solar farm is expected to generate around 52 per cent of the factory’s energy demand.